1. Rosenbaum JT. Acute anterior uveitis and spondyloarthropathies. Rheum Dis Clin North Am. 1992; 18:143–151.
2. Gran JT, Skomsvoll JF. The outcome of ankylosing spondylitis: a study of 100 patients. Br J Rheumatol. 1997; 36:766–771.
3. Robertson LP, Davis MJ. A longitudinal study of disease activity and functional status in a hospital cohort of pa tients with ankylosing spondylitis. Rheumatology (Oxford). 2004; 43:1565–1568.
4. Smith JR. HLA-B27: associated uveitis. Ophthalmol Clin North Am. 2002; 15:297–307.
5. Quinnell RJ. Genetics of susceptibility to human helminth infection. Int J Parasitol. 2003; 33:1219–1231.
6. Despommier D. Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin Microbiol Rev. 2003; 16:265–272.
7. Rubinsky-Elefant G, Hirata CE, Yamamoto JH, Ferreira MU. Human toxocariasis: diagnosis, worldwide seroprevalences and clinical expression of the systemic and ocular forms. Ann Trop Med Parasitol. 2010; 104:3–23.
8. Bocanegra TS, Vasey FB. Musculoskeletal syndromes in parasitic diseases. Rheum Dis Clin North Am. 1993; 19:505–513.
9. Zaccone P, Fehervari Z, Phillips JM, et al. Parasitic worms and inflammatory diseases. Parasite Immunol. 2006; 28:515–523.
10. Peng SL. Rheumatic manifestations of parasitic diseases. Semin Arthritis Rheum. 2002; 31:228–247.
11. Williams D, Roy S. Arthritis and arthralgia associated with toxocaral infestation. Br Med J (Clin Res Ed). 1981; 283:192.
12. Brocq O, Breuil V, Agopian V, et al. Reactive arthritis induced by Strongyloides stercoralis. Rev Rhum Engl Ed. 1996; 63:217–219.
13. Richter J, Muller-Stover I, Strothmeyer H, et al. Arthritis associated with Strongyloides stercoralis infection in HLA B-27-positive African. Parasitol Res. 2006; 99:706–707.
14. Kuk S, Ozgocmen S, Bulut S. Seroprevalance of toxocara antibodies in multiple sclerosis and ankylosing spondylitis. Indian J Med Sci. 2006; 60:297–299.
15. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum. 1984; 27:361–368.
16. Jimenez-Balderas FJ, Camargo-Coronel A, Gargia-Jaimes J, et al. A study on parasites in Mexican rheumatic disease patients. J Egypt Soc Parasitol. 2012; 42:271–280.
17. Altman DG. Practical statistics for medical research. London: Chapman and Hall;1991. p. 229–276.
18. Embil JA, Tanner CE, Pereira LH, et al. Seroepidemiologic survey of Toxocara canis infection in urban and rural children. Public Health. 1988; 102:129–133.
19. Park SP, Park I, Park HY, et al. Five cases of ocular toxocariasis confirmed by serology. Korean J Parasitol. 2000; 38:267–273.
20. Elefant GR, Shimizu SH, Sanchez MC, et al. A serological follow-up of toxocariasis patients after chemotherapy based on the detection of IgG, IgA, and IgE antibodies by enzyme-linked immunosorbent assay. J Clin Lab Anal. 2006; 20:164–172.
21. De Visser L, Rothova A, de Boer JH, et al. Diagnosis of ocular toxocariasis by establishing intraocular antibody production. Am J Ophthalmol. 2008; 145:369–374.
22. Tinoco-Gracia L, Barreras-Serrano A, Lopez-Valencia G, et al. Seroprevalence of larva migrans of toxocara canis and evaluation of associated risk factors among children in a mexico-united states border region. Int J Appl Res Vet Med. 2008; 6:130–136.
23. Romero-Nunez C, Mendoza-Martinez GD, Bustamante LP, et al. Presence and viability of Toxocara spp in soils public parks, gardens and houses in dog feces Nezahualcoyotl, Mexico. Rev Cient. 2011; 21:195–201.
24. Romero Núñez C, Mendoza-Martinez GD, Yanez-Arteaga S, et al. Prevalence and risk factors associated with toxocara canis infection in children. ScientificWorldJournal. 2013; 2013:572089.
25. Ponce-Macotela M, Martinez-Gordillo MN, Caballero Salazar S, et al. Toxocara and toxocariosis. In : Becerril-Flores MA, editor. Medical parasitology. Mexico, M.F.: Mcgraw-Hill-Interamericana;2004. p. 249–256.
26. Martinez-Barbabosa I, Quiroz MG, Gonzalez LA, et al. Prevalence of anti-T. canis antibodies in stray dogs in Mexico City. Vet Parasitol. 2008; 153:270–276.
27. Barisani-Asenbauer T, Maca SM, Hauff W, et al. Treatment of ocular toxocariasis with albendazole. J Ocul Pharmacol Ther. 2001; 17:287–294.
28. Khan MA, Kushner I, Braun WE. Comparison of clinical features in HLA-B27 positive and negative patients with ankylosing spondylitis. Arthritis Rheum. 1977; 20:909–912.
29. Jaakkola E, Herzberg I, Laiho K, et al. Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis. Ann Rheum Dis. 2006; 65:775–780.
30. Niederer R, Danesh-Meyer H. Uveitis screening: HLAB27 antigen and ankylosing spondylitis in a New Zealand population. N Z Med J. 2006; 119:U1886.
31. Braakenburg AM, de Valk HW, de Boer J, Rothova A. Human leukocyte antigen-B27-associated uveitis: long-term follow-up and gender differences. Am J Ophthalmol. 2008; 145:472–479.